DirectSens’ Market-Leading LactoSens® Biosensor Technology Acquired by Kerry Group P.L.C.

Contributed by: Business Wire

Logo

Images

LactoSens®, Industry Gold Standard Biosensor Kit. Developed and manufactured by DirectSens in Vienna, AUSTRIA, © DirectSens GmbH 2024

Business Wire embedded0

Tags

Other Manufacturing

Fitness & Nutrition

Health Technology

Manufacturing

Biotechnology

Food/Beverage

Health

Retail

Science

Other Science

Kerry Group

More Like This

Breaking Ground in Fragrance Innovation: Sensegen and Global Leader Unveil Dynamic Collaboration

21st.BIO obtains self-affirmed GRAS status for its precision fermented beta-lactoglobulin: 21st.BIO customers can now enter the U.S. market with their own production using 21st.BIO technology

21ST.BIO OPENS A MORE SUSTAINABLE AVENUE FOR INDUSTRIAL SCALE DAIRY PROTEIN PRODUCTION

PR Newswire associated0

Lesaffre acquires a majority stake in Biorigin to strengthen and broaden its savory ingredients offering

Left to right are Ross McDermid (CCO) AND Fiona Marshall (CEO) of Biotangents. Technology developed by the Scottish biotech, which has announced its latest investment round, is set to revolutionise the dairy farming industry with the world’s fastest on-farm, point-of-care diagnostic device aimed at addressing disease in dairy cows. Bovine mastitis alone is estimated to cost the global dairy farming industry around £20 billion every year, costing the average UK dairy farm up to £25,000 per annum. (Photo: Business Wire)

Biotangents Set to Revolutionise Dairy Farming Industry as Investment Round Announced

Biognosys Presents Technological Innovations and Scientific Progress to Make the Proteome Actionable for Life Science Research at the HUPO 2023 World Congress

First product based on LTS Sorrel™ wearable drug delivery platform launched in the US

Exosens Signs Partnership With Scientific Imaging Inc.